Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Pharmacotherapy in the addiction treatment – similarities and differences (CROSBI ID 605595)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Kuzman, Marina ; Pejak, Martina Pharmacotherapy in the addiction treatment – similarities and differences // Treatment Delivery Systems: Asserting the Future. Ženeva: International Addiction Treatment Society, 2012. str. 17-17

Podaci o odgovornosti

Kuzman, Marina ; Pejak, Martina

engleski

Pharmacotherapy in the addiction treatment – similarities and differences

Introduction: Substitution therapy is for a long time considered as important and successful treatment of addiction and effective in the prevention of adverse effects caused by use o f the illegal substances. Methadone in opiate substitution therapy has been introduced in Croatia in mid-nineties and buprenorphine in 2007, replaced by buprenorphine with naloxon in 2009. The treatment system for drug addicts is organized within the public health institutes, characterized by open access, services free of charge, no waiting lists and OST paid by health insurance. The Register of persons treated for drug addiction has been maintained since 1980 in the Croatian National Institute of Public Health, collecting data from all health services and therapeutic communities. Aim: Since introduction of buprenorphine, the addicts’ population was offered one of two OST possibilities – methadone or buprenorphine. In 2010 in the treatment services 2797 persons were receiving methadone and 2349 buprenorphine. We investigated the characteristic of the population (gender, age, age of the first use and mode of opiate use, duration of addiction, age at the first treatment, employment, living circumstances, parental marital status, and parental awareness of the addiction). The t-test and chi square test were used. Results: The two subpopulations were similar in many social and environmental characteristics, but those who accepted buprenorphine started i.v. use at the older age (p=0.036), came to the treatment earlier in the life (p=0.004), had shorter duration of addiction (p<0.001), had parents who were often in the marriage (p<0.001) and who recognized their addiction earlier (p=0.001). The gradual changes from methadone to buprenorphine in three years period were analyzed. Conclusion: Although the basic characteristics of the two subpopulation groups were similar, it seems that compliance with the change of the treatment regime or acceptance of the recommended OST is greater in younger persons with shorter history of addiction and from intact families with greater awareness of the problem.

addiction; pharmacotherapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

17-17.

2012.

objavljeno

Podaci o matičnoj publikaciji

Treatment Delivery Systems: Asserting the Future

Ženeva: International Addiction Treatment Society

Podaci o skupu

International Addiction Treatment Conference

predavanje

14.10.2012-18.10.2012

Ženeva, Švicarska

Povezanost rada

nije evidentirano